Northern Trust Corp 180 Life Sciences Corp. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
BUY
$3.27 - $6.38 $16,428 - $32,053
5,024 Added 14.47%
39,737 $155,000
Q3 2021

Nov 15, 2021
BUY
$5.11 - $10.81 $28,845 - $61,022
5,645 Added 19.42%
34,713 $188,000
Q2 2021

Aug 13, 2021
BUY
$6.7 - $11.98 $22,974 - $41,079
3,429 Added 13.37%
29,068 $291,000
Q4 2020

Feb 11, 2021
BUY
$2.15 - $11.17 $55,123 - $286,387
25,639 New
25,639 $70,000

About 180 Life Sciences Corp.

ATNF Quotes by TradingView
  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $81.1M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email